Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2M0P

Solution structure of the tenth complement type repeat of human megalin

Summary for 2M0P
Entry DOI10.2210/pdb2m0p/pdb
Related2FYJ 2i1p
NMR InformationBMRB: 18816
DescriptorLow-density lipoprotein receptor-related protein 2, CALCIUM ION (2 entities in total)
Functional Keywordscomplement type repeat, receptor, megalin, ldl receptor family, lrp2, lipid binding protein
Biological sourceHomo sapiens (human)
Cellular locationMembrane; Single-pass type I membrane protein: P98164
Total number of polymer chains1
Total formula weight5914.24
Authors
Dagil, R.,Kragelund, B. (deposition date: 2012-11-01, release date: 2013-01-09, Last modification date: 2024-11-20)
Primary citationDagil, R.,O'Shea, C.,Nykjar, A.,Bonvin, A.M.,Kragelund, B.B.
Gentamicin binds to the megalin receptor as a competitive inhibitor using the common ligand binding motif of complement type repeats: insight from the nmr structure of the 10th complement type repeat domain alone and in complex with gentamicin.
J.Biol.Chem., 288:4424-4435, 2013
Cited by
PubMed Abstract: Gentamicin is an aminoglycoside widely used in treatments of, in particular, enterococcal, mycobacterial, and severe Gram-negative bacterial infections. Large doses of gentamicin cause nephrotoxicity and ototoxicity, entering the cell via the receptor megalin. Until now, no structural information has been available to describe the interaction with gentamicin in atomic detail, and neither have any three-dimensional structures of domains from the human megalin receptor been solved. To address this gap in our knowledge, we have solved the NMR structure of the 10th complement type repeat of human megalin and investigated its interaction with gentamicin. Using NMR titration data in HADDOCK, we have generated a three-dimensional model describing the complex between megalin and gentamicin. Gentamicin binds to megalin with low affinity and exploits the common ligand binding motif previously described (Jensen, G. A., Andersen, O. M., Bonvin, A. M., Bjerrum-Bohr, I., Etzerodt, M., Thogersen, H. C., O'Shea, C., Poulsen, F. M., and Kragelund, B. B. (2006) J. Mol. Biol. 362, 700-716) utilizing the indole side chain of Trp-1126 and the negatively charged residues Asp-1129, Asp-1131, and Asp-1133. Binding to megalin is highly similar to gentamicin binding to calreticulin. We discuss the impact of this novel insight for the future structure-based design of gentamicin antagonists.
PubMed: 23275343
DOI: 10.1074/jbc.M112.434159
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

240971

數據於2025-08-27公開中

PDB statisticsPDBj update infoContact PDBjnumon